| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3190647 | Annals of Allergy, Asthma & Immunology | 2016 | 6 Pages |
Abstract
The prevalence of tropomyosin was low in mite-sensitized patients (2.7 %) and high in shellfish allergic patients (28.6%). The higher prevalence of tropomyosin was found in patients sensitized to both mite and shellfish (38.5%). The selection of tropomyosin-sensitized patients by SPT might help in the choice of appropriate treatments or management for these patients.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
M. Angeles PhD, Carlos H. MD, Raquel PhD, Inmaculada MD, PhD, Angel MD, PhD, Angel Julio MD, PhD, Isabel MD, Luis Angel MD, PhD, José Luis MD, Sandra MD, Carmen MD, Maribel MD, Jerónimo PhD,